4//SEC Filing
Feldmann Marc 4
Accession 0001013762-21-000206
CIK 0001690080other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 8:52 AM ET
Size
5.4 KB
Accession
0001013762-21-000206
Insider Transaction Report
Form 4
Feldmann Marc
Director10% Owner
Transactions
- Award
Common Stock
2021-09-30$6.00/sh+136,636$819,816→ 2,754,394 total
Footnotes (2)
- [F1]On September 30, 2021, the Issuer entered into a Debt Conversion Agreement with the Reporting Person, pursuant to which the parties agreed to convert an aggregate of $819,818 owed by the Registrant to the Reporting Person, for advances previously made to the Registrant's subsidiaries, into an aggregate of 136,636 shares of common stock of the Issuer. Exempt from Section 16(b) pursuant to Rule 16b-3.
- [F2]The agreed upon conversion price of the conversion of the debt described in Footnote (1) above was the greater of the closing consolidated bid price or the market price on the date the conversion agreement was entered into, and $6.00 per share, provided that because $6.00 was above the closing consolidated bid price and the market price, the conversion price was fixed at $6.00 per share.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001832327
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 8:52 AM ET
- Size
- 5.4 KB